Patents by Inventor Pierre Beaulieu
Pierre Beaulieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11944929Abstract: A filter housing for containing a cartridge assembly having a filter cartridge secured to a filter cover, the filter housing has a peripheral wall extending around a longitudinal axis, and end wall secured to the peripheral wall, the filter housing defining a cavity partially enclosed by the peripheral wall and the end wall, the peripheral wall defining a cartridge-receiving section extending from the end wall along the longitudinal axis and sized for receiving the filter cartridge and a cover-receiving section extending along the longitudinal axis from the cartridge-receiving section to an open end of the filter housing opposed to the end wall and sized for receiving the filter cover, a portion of the cover-receiving section recessed radially outwardly from the cartridge-receiving section relative to the longitudinal axis, a lubricant outlet of the filter housing extending through the portion of the cover-receiving section of the peripheral wall.Type: GrantFiled: May 26, 2022Date of Patent: April 2, 2024Assignee: PRATT & WHITNEY CANADA CORP.Inventors: Rose Beaulieu, Pierre Gauvin, Louis Brillon, Joanna Radon, Sean Powers, Kevin White
-
Patent number: 9399645Abstract: Compounds of formula (I) and pharmaceutical compositions thereof: wherein A1 A2 and A3 are each independently selected from the group consisting of N and CR3, wherein R1 is an optionally substituted heterocyclyl or an optionally substituted —(C1-6)alkyl-heterocyclyl, R2 is an optionally substituted aryl or an optionally subsisted heteroaryl, R4 is an optionally substituted aryl, an optionally substituted heterocyclyl or an optionally substituted heteroaryl, useful as an inhibitor of HIV replication.Type: GrantFiled: December 19, 2012Date of Patent: July 26, 2016Assignee: Boehringer Ingelheim International GmbHInventors: Claudio Sturino, Pierre Beaulieu, Patrick Deroy, Martin Duplessis, Clint James, Jean-Eric Lacoste, Joannie Minville, Louis Morency, Sébastien Morin, Bruno Simoneau, Martin Tremblay
-
Publication number: 20150011531Abstract: Compounds of formula (I) and pharmaceutical compositions thereof: wherein A1 A2 and A3 are each independently selected from the group consisting of N and CR3, wherein R1 is an optionally substituted heterocyclyl or an optionally substituted —(C1-6)alkyl-heterocyclyl, R2 is an optionally substituted aryl or an optionally subsisted heteroaryl, R4 is an optionally substituted aryl, an optionally substituted heterocyclyl or an optionally substituted heteroaryl, useful as an inhibitor of HIV replication.Type: ApplicationFiled: December 19, 2012Publication date: January 8, 2015Applicant: Boehringer Ingelheim International GmbHInventors: Claudio Sturino, Pierre Beaulieu, Patrick Deroy, Martin Duplessis, Clint James, Jean-Eric Lacoste, Joannie Minville, Louis Morency, Sébastien Morin, Bruno Simoneau, Martin Tremblay
-
Publication number: 20120248177Abstract: A padded and recyclable paper envelope is comprised of a front wall, a rear wall, an open edge for access to an interior compartment of the envelope, and a closure flap to close the open edge. A corrugated board is adhesively secured over an inner face of the front wall and rear wall to protect an item disposed in the interior compartment between the reinforcing corrugated board surfaces. The envelope is formed from a single paper blank on which the corrugated board is adhesively secured. The envelope and the corrugated board are formed from recyclable material.Type: ApplicationFiled: March 8, 2012Publication date: October 4, 2012Inventors: Pierre Beaulieu, Gilles Bruneau
-
Publication number: 20120101091Abstract: The present application provides compounds of formula I wherein X, Y, R2, n, R5 and R6 are defined herein, useful as inhibitors of the hepatitis C virus NS5B polymerase The present application also provides pharmaceutical compositions containing said compounds, methods of using said compounds as pharmaceuticals alone or with other antiviral agent in the treatment of a hepatitis C viral infection in a mammal having or at risk of having the infection.Type: ApplicationFiled: October 1, 2009Publication date: April 26, 2012Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Pierre Beaulieu, Pierre Bonneau, René Coulombe, Pasquale Forgione, James Gillard, Araz Jakalian, Jean Rancourt
-
Patent number: 8104811Abstract: A hooking device attaches an equipment like a fall limiter to an anchorage structural element by means of a stick. The device comprises an elongated member to which the equipment is attachable. A hooking head slides along the elongated member. The hooking head has a hook forming an opening in which the anchorage structural element is engageable. An actuating mechanism operates a locking element of the opening in response to a sliding of the hooking head with respect to the elongated member. A stick detachable fastening element is used to slide the hooking head with respect to the elongated member in response to a movement of the stick when the anchorage structural element is engaged in the opening.Type: GrantFiled: February 18, 2008Date of Patent: January 31, 2012Assignee: Hydro-QuebecInventors: Paul Antoine Sèguin, Pierre Beaulieu, Sébastien Riopel, Yves Thibault, Yves Vermette, Bertrand Legrand
-
Patent number: 8030309Abstract: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.Type: GrantFiled: September 27, 2010Date of Patent: October 4, 2011Assignee: Boehringer Ingelheim International GmbHInventors: Youla S. Tsantrizos, Catherine Chabot, Pierre Beaulieu, Christian Brochu, Martin Poirier, Timothy A. Stammers, Bounkham Thavonekham, Jean Rancourt
-
Publication number: 20110230465Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.Type: ApplicationFiled: September 16, 2010Publication date: September 22, 2011Applicant: BOEHRINGER INGLEHEIM INTERNATIONAL GMBHInventors: Timothy STAMMERS, Xavier BARBEAU, Pierre BEAULIEU, Megan BERTRAND-LAPERLE, Christian BROCHU, Paul J. EDWARDS, Pasquale FORGIONE, Cédrickx GODBOUT, Oliver HUCKE, Marc-André JOLY, Serge LANDRY, Olivier LEPAGE, Julie NAUD, Marc PESANT, Martin POIRIER, Maude POIRIER, Bounkham THAVONEKHAM
-
Patent number: 7897622Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.Type: GrantFiled: August 10, 2007Date of Patent: March 1, 2011Assignee: Boehringer Ingelheim International GmbHInventors: Pierre Beaulieu, René Coulombe, Gulrez Fazal, Sylvie Goulet, Martin Poirier, Jean Rancourt, Tim Stammers, Bounkham Thavonekham
-
Patent number: 7879851Abstract: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.Type: GrantFiled: February 17, 2009Date of Patent: February 1, 2011Assignee: Boehringer Ingelheim International GmbHInventors: Youla S. Tsantrizos, Catherine Chabot, Pierre Beaulieu, Christian Brochu, Martin Poirier, Timothy A. Stammers, Bounkham Thavonekham, Jean Rancourt
-
Publication number: 20110015203Abstract: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.Type: ApplicationFiled: September 27, 2010Publication date: January 20, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Youla S. TSANTRIZOS, Catherine CHABOT, Pierre BEAULIEU, Christian BROCHU, Martin POIRIER, Timothy A. STAMMERS, Bounkham THAVONEKHAM, Jean RANCOURT
-
Publication number: 20100101059Abstract: A hooking device for attaching an equipment like a fall limiter to an anchorage structural element by means of a stick. The device comprises an elongated member to which the equipment is attachable. A hooking head slides along the elongated member. The hooking head has a hook forming an opening in which the anchorage structural element is engageable. An actuating mechanism operates a locking element of the opening in response to a sliding of the hooking head with respect to the elongated member. A stick detachable fastening element is used to slide the hooking head with respect to the elongated member in response to a movement of the stick when the anchorage structural element is engaged in the opening.Type: ApplicationFiled: February 18, 2008Publication date: April 29, 2010Inventors: Paul Antoine Séguin, Pierre Beaulieu, Sébastien Riopel, Yves Thibault, Yves Vermette, Bertrand Legrand
-
Patent number: 7582770Abstract: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.Type: GrantFiled: February 18, 2005Date of Patent: September 1, 2009Assignee: Boehringer Ingelheim International GmbHInventors: Youla S. Tsantrizos, Catherine Chabot, Pierre Beaulieu, Christian Brochu, Timothy A. Stammers, Bounkham Thavonekham, Jean Rancourt
-
Publication number: 20090170859Abstract: An enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein, or a salt or ester thereof, as an inhibitor of HCV NS5B polymerase.Type: ApplicationFiled: February 17, 2009Publication date: July 2, 2009Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Youla S. TSANTRIZOS, Catherine CHABOT, Pierre BEAULIEU, Christian BROCHU, Martin POIRIER, Timothy A. STAMMERS, Bounkham THAVONEKHAM, Jean RANCOURT
-
Patent number: 7386398Abstract: The HCV NS5B polymerase, when complexed with certain inhibitors, adopts a conformation in which the finger loop region defined by amino acid residues 18 to 35 is displaced to expose a binding pocket defined generally by amino acid residues 392, 393, 395, 396, 399, 424, 425, 428, 429, 492, 493, 494, 495, 496, 500 and 503. This newly exposed binding pocket defines a novel target in the search of further chemical entities which are capable of binding to HCV NS5B and modulating, or preferably inhibiting, the polymerase activity of HCV NS5B.Type: GrantFiled: May 7, 2004Date of Patent: June 10, 2008Assignee: Boehringer Ingelheim International GmbHInventors: René Coulombe, Pierre Beaulieu, Eric Jolicoeur, George Kukolj, Steven Laplante, Marc-André Poupart
-
Publication number: 20080045516Abstract: Compounds of formula I: wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.Type: ApplicationFiled: August 10, 2007Publication date: February 21, 2008Inventors: Pierre Beaulieu, Rene Coulombe, Gulrez Fazal, Sylvie Goulet, Martin Poirier, Jean Rancourt, Timothy Stammers, Bounkham Thavonekham
-
Publication number: 20070249629Abstract: A compound, represented by formula (I): wherein A, B, R1, R2, R3, R5, R6, R7, R9, and R10 are as defined herein, or an enantiomer, diastereoisomer or tautomer thereof, including a salt, ester or derivative thereof, as an inhibitor of HCV NS5B polymerase.Type: ApplicationFiled: May 25, 2007Publication date: October 25, 2007Inventors: Pierre BEAULIEU, Christian Brochu, Stephen Kawai, Jean Rancourt, Timothy Stammers, Bounkham Thavonekham, Youla Tsantrizos
-
Patent number: 7241801Abstract: A compound, represented by formula (I): wherein A, B, R1, R2, R3, R5, R6, R7, R9, and R10 are as defined herein, or an enantiomer, diastereoisomer or tautomer thereof, including a salt, ester or derivative thereof, as an inhibitor of HCV NS5B polymerase.Type: GrantFiled: July 15, 2005Date of Patent: July 10, 2007Assignee: Boehringer Ingelheim International GmbHInventors: Pierre Beaulieu, Christian Brochu, Stephen Kawai, Jean Rancourt, Timothy A. Stammers, Bounkham Thavonekham, Youla S. Tsantrizos
-
Publication number: 20070142380Abstract: An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R2, R3, L, M1, M2, M3, M4, Y1, Y0, Z and Sp are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase.Type: ApplicationFiled: February 7, 2007Publication date: June 21, 2007Applicant: Boehringer Ingelheim International GmbHInventors: Pierre Beaulieu, Christian Brochu, Catherine Chabot, Eric Jolicoeur, Stephen Kawai, Marc-Andre Poupart, Youla Tsantrizos
-
Publication number: 20060293306Abstract: An isomer, enantiomer, diastereoisomer, or tautomer of a compound, represented by formula I: wherein: A is O, S, NR1, or CR1, wherein R1 is defined herein; — represents either a single or a double bond; R2 is selected from: H, halogen, R21, OR21, SR21, COOR21, SO2N(R22)2, N(R22)2, CON(R22)2, NR22C(O)R22 or NR22C(O)NR22 wherein R21 and each R22 is defined herein; B is NR3 or CR3, with the proviso that one of A or B is either CR1 or CR3, wherein R3 is defined herein; K is N or CR4, wherein R4 is defined herein; L is N or CR5 wherein R5 has the same definition as R4 defined above; M is N or CR7, wherein R7 has the same definition as R4 defined above; Y1 is O or S; Z is N(R6a)R6 or OR6, wherein R6a is H or alkyl or NR61R62 wherein R61 and R62 are defined herein; a salt or a derivative thereof, as an inhibitor of HCV NS5B polymerase.Type: ApplicationFiled: August 15, 2006Publication date: December 28, 2006Inventors: Pierre Beaulieu, Gulrez Fazal, George Kukolj, Eric Jolicoeur, James Gillard, Marc-Andre Poupart, Jean Rancourt